CardioMEMS HF System OUS Post Market Study
NCT02954341
Cardiovascular Diseases, Congestive Heart Failure
Chermside, Queensland, Australia
View Trial DetailsNCT Number: NCT04836702
Patient with coronary artery disease (CAD), heart failure and abnormal heart function undergoing major vascular surgery have a high associated high morbidity and mortality with myocardial infarction accounting for 33-50% of perioperative deaths. The prevalence of CAD in vascular surgery patients approaches 50%. Proper pre-procedure protocols to accurately assess patients and determine who may require further medical optimization prior to undergoing surgery help mitigate risk and improve outcomes. The investigators designed this study as a single center, retrospective cohort analysis to explore the association between ventricular (LV and RV function) and valvular (Aortic / Mitral / Tricuspid) function and expanded major adverse cardiac events (X-MACE).
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: In-hospital admission (within 120 days of index surgery)
Composite outcome defined as any cardiovascular death, non-fatal MI, non-fatal stroke, post-operative CHF, or new dysrhythmias, all within the index hospital admission.
University of Virginia
Other
Vascular Surgery Outcomes: Echocardiography as Risk-Assessment for Major Adverse Cardiac Events in Major Vascular Surgery Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02954341
Cardiovascular Diseases, Congestive Heart Failure
Chermside, Queensland, Australia
View Trial DetailsNCT02279888
Cardiovascular Diseases, Congestive Heart Failure
Morgantown, West Virginia, United States
View Trial DetailsNCT02340546
Cardiovascular Diseases, Heart Diseases
Bologna, BO, Italy
View Trial DetailsNCT02885636
Cardiovascular Diseases, Congestive Heart Failure
Rochester, Minnesota, United States
View Trial Details